scholarly journals Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-κB

2007 ◽  
Vol 204 (2) ◽  
pp. 259-265 ◽  
Author(s):  
Polyxeni Gourzi ◽  
Tatyana Leonova ◽  
F. Nina Papavasiliou

Activation-induced cytidine deaminase (AID) is expressed in germinal centers of lymphoid organs during immunoglobulin diversification, in bone marrow B cells after infection with Abelson murine leukemia retrovirus (Ab-MLV), and in human B cells after infection by hepatitis C virus. To understand how viruses signal AID induction in the host we asked whether the AID response was abrogated in cells deficient in the interferon pathway or in signaling via the Toll-like receptors. Here we show that AID is not an interferon responsive gene and abrogation of Toll-like receptor signaling does not diminish the AID response. However, we found that NF-κB was required for expression of virally induced AID. Since NF-κB binds and activates the AID promoter, these results mechanistically link viral infection with AID transcription. Thus, induction of AID by viruses could be the result of several signaling pathways that culminate in NF-κB activation, underscoring the versatility of this host defense program.

PLoS ONE ◽  
2014 ◽  
Vol 9 (5) ◽  
pp. e96381 ◽  
Author(s):  
Dániel Szili ◽  
Zsuzsanna Bankó ◽  
Eszter Angéla Tóth ◽  
György Nagy ◽  
Bernadette Rojkovich ◽  
...  

2008 ◽  
Vol 181 (11) ◽  
pp. 7825-7834 ◽  
Author(s):  
Nancy S. Longo ◽  
Gabrielle J. Grundy ◽  
Jisoo Lee ◽  
Martin Gellert ◽  
Peter E. Lipsky

Blood ◽  
2008 ◽  
Vol 112 (12) ◽  
pp. 4675-4682 ◽  
Author(s):  
Xiaosheng Wu ◽  
Jaime R. Darce ◽  
Sook Kyung Chang ◽  
Grzegorz S. Nowakowski ◽  
Diane F. Jelinek

Abstract The mutagenic enzyme activation-induced cytidine deaminase (AID) is required for immunoglobulin class switch recombination (CSR) and somatic hypermutation (SHM) in germinal center (GC) B cells. Deregulated expression of AID is associated with various B-cell malignancies and, currently, it remains unclear how AID activity is extinguished to avoid illegitimate mutations. AID has also been shown to be alternatively spliced in malignant B cells, and there is limited evidence that this also occurs in normal blood B cells. The functional significance of these splice variants remains unknown. Here we show that normal GC human B cells and blood memory B cells similarly express AID splice variants and show for the first time that AID splicing variants are singly expressed in individual normal B cells as well as malignant B cells from chronic lymphocytic leukemia patients. We further demonstrate that the alternative AID splice variants display different activities ranging from inactivation of CSR to inactivation or heightened SHM activity. Our data therefore suggest that CSR and SHM are differentially switched off by varying the expression of splicing products of AID at the individual cell level. Most importantly, our findings suggest a novel tumor suppression mechanism by which unnecessary AID mutagenic activities are promptly contained for GC B cells.


2018 ◽  
Vol 101 ◽  
pp. 419-428 ◽  
Author(s):  
Timothy Recaldin ◽  
Philip S. Hobson ◽  
Elizabeth H. Mann ◽  
Faruk Ramadani ◽  
David J. Cousins ◽  
...  

2008 ◽  
Vol 180 (8) ◽  
pp. 5283-5290 ◽  
Author(s):  
Daniela Frasca ◽  
Ana Marie Landin ◽  
Suzanne C. Lechner ◽  
John G. Ryan ◽  
Robert Schwartz ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (2) ◽  
pp. e31341 ◽  
Author(s):  
Guilhem Richard ◽  
Calin Belta ◽  
A. Agung Julius ◽  
Salomon Amar

Sign in / Sign up

Export Citation Format

Share Document